Protein Engineering Allows for Mild Affinity-based Elution of Therapeutic Antibodies

0Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

Presented here is an engineered protein domain, based on Protein A, that displays a calcium-dependent binding to antibodies. This protein, ZCa, is shown to efficiently function as an affinity ligand for mild purification of antibodies through elution with ethylenediaminetetraacetic acid. Antibodies are commonly used tools in the area of biological sciences and as therapeutics, and the most commonly used approach for antibody purification is based on Protein A using acidic elution. Although this affinity-based method is robust and efficient, the requirement for low pH elution can be detrimental to the protein being purified. By introducing a calcium-binding loop in the Protein A-derived Z domain, it has been re-engineered to provide efficient antibody purification under mild conditions. Through comprehensive analyses of the domain as well as the ZCa–Fc complex, the features of this domain are well understood. This novel protein domain provides a very valuable tool for effective and gentle antibody and Fc-fusion protein purification.

Cite

CITATION STYLE

APA

Kanje, S., Venskutonytė, R., Scheffel, J., Nilvebrant, J., Lindkvist-Petersson, K., & Hober, S. (2018). Protein Engineering Allows for Mild Affinity-based Elution of Therapeutic Antibodies. Journal of Molecular Biology, 430(18), 3427–3438. https://doi.org/10.1016/j.jmb.2018.06.004

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free